(Q44044259)

29 November 2017

title

Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan (English)

1 reference

29 November 2017

main subject

Gram-negative bacteria

0 references

author

Chang Shan-chwen

4

1 reference

29 November 2017

Wang-Huei Sheng

1

0 references

Jann-Tay Wang

object named as

Jann-Tay Wang

3

0 references

Yee-Chun Chen

object named as

Yee-Chun Chen

2

0 references

Kwen-Tay Luh

5

object named as

Kwen-Tay Luh

1 reference

29 November 2017

Wei-Chuan Hsieh

6

1 reference

29 November 2017

publication date

1 June 2002

1 reference

Diagnostic Microbiology and Infectious Disease

29 November 2017

published in

1 reference

29 November 2017

volume

43

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

141-147

1 reference

The clinical problems of bacterial resistance to the new quinolones

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Trends in bacterial resistance to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Cross-resistance and cross-susceptibility between fluoroquinolone agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Analysis of 1,186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Fluoroquinolone resistance among methicillin-resistant staphylococci after usage of fluoroquinolones other than ciprofloxacin in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Macrolides resistance of common bacteria isolated from Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

High Prevalence of Antibiotic Resistance of Common Pathogenic Bacteria in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Klebsiella pneumoniae isolates causing liver abscess in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

In vitro and in vivo evaluations of A-80556, a new fluoroquinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

In vitro activity of Bay y 3118, a new quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Fluoroquinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Fluoroquinolone resistance an evolving national problem or just a problem for some physicians?

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

In vitro antibacterial activity of DU-6859a, a new fluoroquinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Fluoroquinolone resistance: overuse of fluoroquinolones in human and veterinary medicine can breed resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Antimicrobial activity of DV-7751a, a new fluoroquinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

Fluoroquinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900381-4

7 January 2021

10.1016/S0732-8893(02)00381-4

Identifiers

DOI

1 reference

29 November 2017

1 reference